Important note

This AI stock analysis for Tilray is not up to date. Creating and accessing our AI stock Analysis (powered by our data and Chat GPT) is only available for our premium users. Sign up to get access today!


Tilray - AI Stock Analysis

Analysis generated January 24, 2025

Tilray, Inc. is a global pioneer in cannabis research, cultivation, processing, and distribution. Established in Canada, the company is known for its high-quality medical cannabis and has expanded its product offerings into the adult-use and wellness markets. Its extensive supply chain initiatives and established international presence set it apart as a key player in the burgeoning cannabis industry.

Fundamental Analysis

For Q2 2023, Tilray reported a revenue of $178 million. While this showcases a growth of 4.06% year-over-year, it reflects a decline of 16.45% from the previous quarter. Such a drop quarter-over-quarter might point to cyclical challenges or market-specific slowdowns that demand further investigation.

Tilray's net income for the same quarter was $85 million, marking a remarkable downturn by 117.90% compared to the previous quarter. This shift to negative profitability raises red flags, especially when considered alongside the 19.32% decrease from the previous year's same quarter. Companies can often recover from occasional setbacks, but consistent profitability is crucial for long-term success.

Similarly, the company's EBITDA was $19 million, down by 30.64% from the prior quarter and 58.94% year-over-year. EBITDA is a critical measure of a company's operating performance, and such significant declines could signal operational issues or inefficiencies that need addressing.

Technical Analysis

Today’s stock price for Tilray stands at $1.18, representing a 16.31% decrease from a month ago and a 40.70% dip from the price a year ago. While the short-term downturn is noticeable, the long-term decline is even more pressing, which may deter risk-averse investors.

The stock's Simple Moving Average (SMA10) is stable at $1.18, reflecting a neutral trend with no significant changes. The Relative Strength Index (RSI) of 43.6 further corroborates this neutral outlook, indicating that the stock is neither overbought nor oversold. Thus, any short-term trading strategies should be approached conservatively.

Alternative Data Analysis

From an alternative data perspective, Tilray shows 77 open job positions, a number stable over the last few months. This steadiness suggests no immediate expansion or contraction plans, reflective of perhaps a cautious approach in a volatile market.

However, the employee sentiment is less optimistic, with only 37% expressing a positive outlook on the company. The slight upward trend of 19% in the past few months is encouraging but still below the desired level for a thriving corporate culture.

Customer acquisition metrics reveal a declining trend, with the company's website attracting 34,000 visitors, down by 8% in recent months. This decrease in traffic could translate to fewer new customers and potentially decreased future revenue.

Customer engagement on social media shows Tilray has 34,000 followers on Twitter, which has remained stable yet this stagnation indicates a plateau in attracting new interest and engagement from potential investors and customers.

The AltIndex AI score for Tilray is pegged at 50, suggesting a neutral "hold" signal. This score, aggregated from various data points, indicates that market experts remain cautious about any significant upward or downward moves in the near term.

Conclusion and Recommendation

Given the mixed signals from fundamental, technical, and alternative data analyses, Tilray is currently at a crossroads. The declining revenue, net income, and EBITDA raise immediate concerns about its operational efficiency and profitability. In technical terms, the stock's neutral trend suggests a wait-and-watch strategy.

The slight improvement in employee sentiment and the neutral AltIndex score indicate that all hope is not lost, but significant improvements are required to regain investor confidence. The decrease in customer acquisition and social media engagement further add layers of complexity to Tilray's strategic focus areas.

With the provided data, a conservative approach is advisable—monitor closely for any operational improvements or market catalysts that may tilt the scales towards a more defined buy or sell recommendation.

Disclaimer: This AI stock analysis, generated by an experimental AI tool, is for informational purposes only and not financial advice. Information is based on publicly available data and may not always be accurate or current.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2025 AltIndex. All rights reserved.